PLUMAS BANCORP quarterly report, Q3 FY2014

Plumas Bancorp — Q3 2014 Form 10-Q

Business context and reporting period. Plumas Bancorp is a California bank holding company whose subsidiary, Plumas Bank, operates 11 branches and lending offices. Its primary business is lending to individuals and small and middle-market businesses in northeastern California and northwestern Nevada. This unaudited filing covers the quarter and nine months ended September 30, 2014; balance-sheet comparisons are with December 31, 2013. Amounts below are in U.S. dollars.

Key financial metrics

MetricQ3 2014Q3 2013Nine months 2014Nine months 2013
Interest income$5.302 million$5.026 million$15.479 million$14.495 million
Net interest income, before loan-loss provision$4.870 million$4.605 million$14.191 million$13.396 million
Net interest margin4.01%4.00%4.01%4.09%
Net income$1.327 million$1.007 million$3.394 million$2.515 million
Diluted EPS$0.27$0.20$0.68$0.56
Provision for loan losses$300,000$100,000$750,000$1.200 million
Non-interest income$1.895 million$1.531 million$5.476 million$4.929 million
Non-interest expense$4.288 million$4.353 million$13.313 million$13.029 million

The filing does not present a single total-revenue line. Interest income plus non-interest income was $7.197 million for Q3 2014 versus $6.557 million a year earlier, and $20.955 million for the first nine months versus $19.424 million.

Balance sheet, liquidity, and capital at September 30, 2014

  • Total assets were $543.1 million, up $27.4 million from year-end 2013. Net loans were $359.2 million, up $24.8 million; gross loans grew 7.1% from year-end.
  • Cash and cash equivalents were $62.2 million, up $12.3 million from year-end. Available-for-sale securities were $84.3 million, down $6.0 million.
  • Deposits were $472.2 million, up $22.8 million. Non-interest-bearing deposits rose $19.1 million; time deposits declined $5.5 million. The company reported no brokered deposits.
  • Shareholders’ equity was $34.7 million, up $4.1 million. The Bank’s total risk-based capital ratio was 14.2%; Bancorp’s was 14.3%. Both exceeded the stated 10% well-capitalized threshold.
  • Debt and funding included an outstanding $1.0 million note payable, $7.4 million subordinated debenture, $10.3 million junior subordinated debentures, and $11.5 million in repurchase agreements. The company reported no outstanding FHLB or correspondent-bank line borrowings; available FHLB borrowing capacity based on then-current stock holdings was $50.6 million.

Cash flows and asset quality

  • For the first nine months, operating cash flow was $4.9 million, investing cash outflow was $15.8 million, and financing cash inflow was $23.2 million. Cash increased $12.3 million during the period to $62.2 million.
  • Nonperforming loans were $5.9 million, or 1.64% of loans, versus $5.5 million and 1.64% at year-end. Nonperforming assets declined to $9.9 million, or 1.82% of assets, from $12.0 million and 2.33%.
  • The allowance for loan losses was $5.3 million, 1.45% of gross loans, compared with $5.5 million and 1.63% at year-end. Nine-month net charge-offs were $1.0 million, or an annualized 0.39% of average loans, versus $1.6 million and 0.66% in the prior-year period.
  • OREO declined to $3.9 million from $6.4 million at year-end. Recorded impaired loans were $7.9 million, down from $9.8 million.

Material changes versus comparable periods

  • For the first nine months, net income increased $879,000. Management attributed the improvement mainly to $795,000 higher net interest income, a $450,000 lower loan-loss provision, and $547,000 higher non-interest income, partly offset by higher operating expenses and income taxes.
  • Loan growth and a higher average securities yield lifted interest income, while the average loan yield fell 24 basis points to 5.46% for the nine-month period amid local price competition. Net interest margin declined 8 basis points year over year.
  • Q3 net income rose $320,000 year over year. Net interest income increased $265,000 and non-interest income rose $364,000; the quarterly loan-loss provision increased $200,000.
  • Non-interest income included a $128,000 gain on securities sales in 2014; no securities were sold in the comparable 2013 period. Q3 gains on loan sales were $304,000 versus $170,000.
  • Net interest income growth was supported by loan volume, but higher borrowing costs included interest on the subordinated debenture issued in 2013 and the note payable issued in October 2013. During August 2014, the company repaid $2.0 million of the note.

Outlook, commentary, risks, and contingencies

  • Outlook: The filing provides no specific earnings or growth guidance. Management said available funding sources, including borrowing capacity, should provide adequate liquidity for foreseeable operations and considered the loan-loss allowance appropriate. Management cautioned that actual losses could exceed the allowance.
  • Credit and concentration risks: Real-estate-related lending represented about 74% of the loan portfolio. Commercial real estate was the largest loan category, and management identified construction and land-development lending as higher risk. The company’s geographic concentration exposes it to regional economic and real-estate conditions, as well as earthquakes, fires, and floods.
  • Market and operating risks: Management cited competition, interest-rate changes and potential margin pressure, regional or national economic weakness, real-estate fluctuations, regulatory changes, key-personnel loss, operational failures or fraud, and securities-market changes.
  • Commitments: Unfunded loan commitments totaled approximately $90.0 million, including $14.6 million of real-estate construction commitments expected to fund within 12 months. Management noted that some commitments may expire undrawn and therefore do not necessarily represent future cash needs.
  • Debt and regulatory capital: The July 2014 modification of the note payable extended maturity to October 2015 and raised its maximum to $7.5 million, subject to conditions. The company stated that its subordinated debenture will not qualify as regulatory capital under Basel III rules effective beginning in 2015; management expected the Bank to remain well capitalized under the new rules.
  • Unusual items and contingencies: The company sold its largest OREO property in June for a $28,000 gain. A one-time adjustment to accrued life-insurance costs reduced Q3 expenses by approximately $90,000. Management said ordinary-course legal proceedings were not expected to materially affect the company; no material litigation amount was specified.

Important facts for investors to verify

  • Whether loan and deposit growth can continue without further margin compression, given falling loan yields and competitive pricing.
  • Whether the allowance remains adequate as nonaccrual loans and 30–89-day past-due loans increased from year-end, despite lower overall nonperforming assets.
  • The performance and credit quality of the growing auto portfolio, construction and land-development loans, and real-estate-heavy loan book.
  • Whether securities-sale gains and other non-recurring expense benefits affect comparisons with future periods.
  • The terms, conditions, and availability of the modified note and borrowing facilities, and the impact of Basel III capital treatment on the company’s capital position.
  • How the $90.0 million of unfunded commitments, repurchase agreements, and deposit trends could affect future liquidity needs.